Who
Jan Pinkas
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Crescent Biopharma.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $70K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Jul 2025
- Last trade
- 16 Sep 2026
- Last filed
- 18 Sep 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Sep 2026filed 18 Sep 2026 | CBIO Crescent BiopharmaBiotechnology | SEC FORM 4 Sold | $12K658 at $17.90 | filing |
| 16 Sep 2026filed 18 Sep 2026 | CBIO Crescent BiopharmaBiotechnology | SEC FORM 4 Sold | $12K658 at $17.90 | filing |
| 22 Jun 2026filed 23 Jun 2026 | CBIO Crescent BiopharmaBiotechnology | SEC FORM 4 Sold | $23K1,288 at $17.99 | filing |
| 22 Jun 2026filed 23 Jun 2026 | CBIO Crescent BiopharmaBiotechnology | SEC FORM 4 Sold | $23K1,288 at $17.99 | filing |
| 15 Dec 2025filed 17 Dec 2025 | CBIO Crescent Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,025 at $0.00 | filing |
| 15 Dec 2025filed 17 Dec 2025 | CBIO Crescent BiopharmaBiotechnology | SEC FORM 4 Code A | —17,507 | filing |
| 15 Dec 2025filed 17 Dec 2025 | CBIO Crescent BiopharmaBiotechnology | SEC FORM 4 Code A | —5,000 | filing |
| 16 Jul 2025filed 16 Jul 2025 | CBIO Crescent Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —142,474 at $0.00 | filing |
News
Jan Pinkas Sells 658 Shares of Crescent Biopharma (NASDAQ:CBIO) Stocktickerreport.com · 18 Sep 2026
1 headline in the last 90 days name Jan Pinkas; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.